Early-Stage Clinical Trial of AI-Driven CBCT-Guided Adaptive Radiotherapy for Lung Cancer

NIH RePORTER · NIH · R21 · $195,556 · view on reporter.nih.gov ↗

Abstract

According to NOT-OD-24-001, the parent abstract is at the beginning of the research strategy: “The Research Strategy section should include a summary or abstract of the funded parent award”

Key facts

NIH application ID
11038651
Project number
3R21EB033994-02S1
Recipient
EMORY UNIVERSITY
Principal Investigator
Aparna Kesarwala
Activity code
R21
Funding institute
NIH
Fiscal year
2024
Award amount
$195,556
Award type
3
Project period
2023-05-01 → 2026-04-30